相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Verteporfin targeting YAP1/TAZ-TEAD transcriptional activity inhibits the tumorigenic properties of gastric cancer stem cells
Julie Giraud et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Verteporfin inhibits oxidative phosphorylation and induces cell death specifically in glioma stem cells
Kenta Kuramoto et al.
FEBS JOURNAL (2020)
The role of liposomes in clinical nanomedicine development. What now? Now what?
Daan J. A. Crommelin et al.
JOURNAL OF CONTROLLED RELEASE (2020)
Zinc finger protein 367 promotes metastasis by inhibiting the Hippo pathway in breast cancer
Xianqiu Wu et al.
ONCOGENE (2020)
Photodynamic Therapy in Primary Breast Cancer
Shramana M. Banerjee et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Heat shock protein 90-targeted photodynamic therapy enables treatment of subcutaneous and visceral tumors
Kensuke Kaneko et al.
COMMUNICATIONS BIOLOGY (2020)
PHOTODYNAMIC THERAPY AS PRIMARY TREATMENT FOR SMALL CHOROIDAL MELANOMA
Elif B. Turkoglu et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2019)
Long noncoding RNA NSCLCAT1 increases non-small cell lung cancer cell invasion and migration through the Hippo signaling pathway by interacting with CDH1
Wei Zhao et al.
FASEB JOURNAL (2019)
SS18-SSX-Dependent YAP/TAZ Signaling in Synovial Sarcoma
Ilka Isfort et al.
CLINICAL CANCER RESEARCH (2019)
Requirement for YAP1 signaling in myxoid liposarcoma
Marcel Trautmann et al.
EMBO MOLECULAR MEDICINE (2019)
Targeted and Synergic Glioblastoma Treatment: Multifunctional Nanoparticles Delivering Verteporfin as Adjuvant Therapy for Temozolomide Chemotherapy
Diogo S. Pellosi et al.
MOLECULAR PHARMACEUTICS (2019)
Core-matched nanoassemblies for targeted co-delivery of chemotherapy and photosensitizer to treat drug-resistant cancer
Di Jiang et al.
ACTA BIOMATERIALIA (2019)
A brief review: some compounds targeting YAP against malignancies
Zhenxue Tang et al.
FUTURE ONCOLOGY (2019)
Aberrant activation of CYR61 enhancers in colorectal cancer development
Lingzhu Xie et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Targeting Cancer Stem Cells: A Strategy for Effective Eradication of Cancer
Masahiro Shibata et al.
CANCERS (2019)
YAP promotes multi-drug resistance and inhibits autophagy-related cell death in hepatocellular carcinoma via the RAC1-ROS-mTOR pathway
Yuan Zhou et al.
CANCER CELL INTERNATIONAL (2019)
On the relationship of YAP and FAK in hMSCs and osteosarcoma cells: Discrimination of FAK modulation by nuclear YAP depletion or YAP silencing
Ayman Husari et al.
CELLULAR SIGNALLING (2019)
YAP promotes the malignancy of endometrial cancer cells via regulation of IL-6 and IL-11
Jing Wang et al.
MOLECULAR MEDICINE (2019)
Central serous chorioretinopathy: Towards an evidence-based treatment guideline
Thomas J. van Rijssen et al.
PROGRESS IN RETINAL AND EYE RESEARCH (2019)
Nanoemulsion Structural Design in Co-Encapsulation of Hybrid Multifunctional Agents: Influence of the Smart PLGA Polymers on the Nanosystem-Enhanced Delivery and Electro-Photodynamic Treatment
Urszula Bazylinska et al.
PHARMACEUTICS (2019)
Verteporfin-induced lysosomal compartment dysregulation potentiates the effect of sorafenib in hepatocellular carcinoma
Jacopo Gavini et al.
CELL DEATH & DISEASE (2019)
Identification of Celastrol as a Novel YAP-TEAD Inhibitor for Cancer Therapy by High Throughput Screening with Ultrasensitive YAP/TAZ-TEAD Biosensors
Kazem Nouri et al.
CANCERS (2019)
Verteporfin-Loaded Lipid Nanoparticles Improve Ovarian Cancer Photodynamic Therapy In Vitro and In Vivo
Thierry Michy et al.
CANCERS (2019)
Role of inhibitor of yes-associated protein 1 in triple-negative breast cancer with taxol-based chemoresistance
Ying Li et al.
CANCER SCIENCE (2019)
Fluorescence polarization assay for the identification and evaluation of inhibitors at YAP-TEAD protein-protein interface 3
Wei Zhou et al.
ANALYTICAL BIOCHEMISTRY (2019)
Antiproliferative and Antimigratory Effects of a Novel YAP-TEAD Interaction Inhibitor Identified Using in Silico Molecular Docking
Sarah A. Smith et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
ROCK2 deprivation leads to the inhibition of tumor growth and metastatic potential in osteosarcoma cells through the modulation of YAP activity
Cinzia Zucchini et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
MAP4K3/GLK in autoimmune disease, cancer and aging
Huai-Chia Chuang et al.
JOURNAL OF BIOMEDICAL SCIENCE (2019)
The transition of tissue inhibitor of metalloproteinases from-4 to-1 induces aggressive behavior and poor patient survival in dedifferentiated liposarcoma via YAP/TAZ activation
Madhu Shrestha et al.
CARCINOGENESIS (2019)
Verteporfin blocks Clusterin which is required for survival of gastric cancer stem cell by modulating HSP90 function
Jixian Xiong et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2019)
Developing Therapies for Age-related Macular Degeneration: The Art and Science of Problem-solving The 2018 Charles L. Schepens, MD, Lecture
Joan W. Miller
OPHTHALMOLOGY RETINA (2019)
Small-Molecule Covalent Modification of Conserved Cysteine Leads to Allosteric Inhibition of the TEAD•Yap Protein-Protein Interaction
Khuchtumur Bum-Erdene et al.
CELL CHEMICAL BIOLOGY (2019)
Differential gene expression induced by Verteporfin in endometrial cancer cells
Lisa Gahyun Bang et al.
SCIENTIFIC REPORTS (2019)
Nestin expression is dynamically regulated in cardiomyocytes during embryogenesis
Vanessa Hertig et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
Targeting Transcriptional Enhanced Associate Domains (TEADs)
Floriane Gibault et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Structural and ligand-binding analysis of the YAP-binding domain of transcription factor TEAD4
Yan Li et al.
BIOCHEMICAL JOURNAL (2018)
Photodynamic therapy - mechanisms, photosensitizers and combinations
Stanislaw Kwiatkowski et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Photodynamic therapy for choroidal carcinoid metastasis
Chia-Kai Chu et al.
CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE (2018)
The Photosensitising Clinical Agent Verteporfin Is an Inhibitor of SPAK and OSR1 Kinases
Mubarak A. AlAmri et al.
CHEMBIOCHEM (2018)
S1P Stimulates Proliferation byUpregulating CTGF Expression through S1PR2-Mediated YAP Activation
Jung-Chien Cheng et al.
MOLECULAR CANCER RESEARCH (2018)
Doxycycline modulates VEGF-A expression: Failure of doxycycline-inducible lentivirus shRNA vector to knockdown VEGF-A expression in transgenic mice
Mari Merentie et al.
PLOS ONE (2018)
p62 as a therapeutic target for inhibition of autophagy in prostate cancer
Lei Wang et al.
PROSTATE (2018)
miR-375 is involved in Hippo pathway by targeting YAP1/TEAD4-CTGF axis in gastric carcinogenesis
Wei Kang et al.
CELL DEATH & DISEASE (2018)
A low microRNA-630 expression confers resistance to tyrosine kinase inhibitors in EGFR-mutated lung adenocarcinomas via miR-630/YAP1/ERK feedback loop
De-Wei Wu et al.
THERANOSTICS (2018)
Toward the Discovery of a Novel Class of YAP-TEAD Interaction Inhibitors by Virtual Screening Approach Targeting YAP-TEAD Protein-Protein Interface
Floriane Gibault et al.
CANCERS (2018)
EGF Receptor-Dependent YAP Activation Is Important for Renal Recovery from AKI
Jianchun Chen et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2018)
Contact inhibition controls cell survival and proliferation via YAP/TAZ-autophagy axis
Mariana Pavel et al.
NATURE COMMUNICATIONS (2018)
Verteporfin selectively kills hypoxic glioma cells through iron-binding and increased production of reactive oxygen species
Katherine L. Eales et al.
SCIENTIFIC REPORTS (2018)
Helicobacter pylori CagA promotes epithelial mesenchymal transition in gastric carcinogenesis via triggering oncogenic YAP pathway
Nianshuang Li et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Co-Administered Polymeric Nano-Antidotes for Improved Photo-Triggered Response in Glioblastoma
Janel Kydd et al.
PHARMACEUTICS (2018)
Induction of Chromosome Instability by Activation of Yes-Associated Protein and Forkhead Box M1 in Liver Cancer
Sofia M. E. Weiler et al.
GASTROENTEROLOGY (2017)
Targeting YAP in malignant pleural mesothelioma
Wen-Qian Zhang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2017)
YAP transcriptionally regulates COX-2 expression and GCCSysm-4 (G-4), a dual YAP/COX-2 inhibitor, overcomes drug resistance in colorectal cancer
Wei Li et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2017)
Verteporfin based silica nanoparticle for in vitro selective inhibition of human highly invasive melanoma cell proliferation
Manuela Rizzi et al.
JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY (2017)
Targeting Phosphatidylinositol 3-Kinase Signaling Pathway for Therapeutic Enhancement of Vascular-Targeted Photodynamic Therapy
Daniel Kraus et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Mechanobiology of YAP and TAZ in physiology and disease
Tito Panciera et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2017)
Targeting YAP/TAZ-TEAD protein-protein interactions using fragment-based and computational modeling approaches
Hung Yi Kristal Kaan et al.
PLOS ONE (2017)
Regulation of the Hippo Pathway Transcription Factor TEAD
Kimberly C. Lin et al.
TRENDS IN BIOCHEMICAL SCIENCES (2017)
Photodynamic-Immune Checkpoint Therapy Eradicates Local and Distant Tumors by CD8+ T Cells
Jan Willem Kleinovink et al.
CANCER IMMUNOLOGY RESEARCH (2017)
Importance of CD200 expression by tumor or host cells to regulation of immunotherapy in a mouse breast cancer model
Anna Curry et al.
PLOS ONE (2017)
Verteporfin-induced formation of protein cross-linked oligomers and high molecular weight complexes is mediated by light and leads to cell toxicity
Eleni K. Konstantinou et al.
SCIENTIFIC REPORTS (2017)
Verteporfin inhibits growth of human glioma in vitro without light activation
Ahmad Al-Moujahed et al.
SCIENTIFIC REPORTS (2017)
YAP/TAZ-Mediated Upregulation of GAB2 Leads to Increased Sensitivity to Growth Factor-Induced Activation of the PI3K Pathway
Chao Wang et al.
CANCER RESEARCH (2017)
Verteporfin suppresses cell survival, angiogenesis and vasculogenic mimicry of pancreatic ductal adenocarcinoma via disrupting the YAP-TEAD complex
Honglong Wei et al.
CANCER SCIENCE (2017)
YAP induces high-grade serous carcinoma in fallopian tube secretory epithelial cells
G. Hua et al.
ONCOGENE (2016)
New photosensitizers for photodynamic therapy
Heidi Abrahamse et al.
BIOCHEMICAL JOURNAL (2016)
WW domain binding protein 5 induces multidrug resistance of small cell lung cancer under the regulation of miR-335 through the Hippo pathway
Ruixiang Tang et al.
BRITISH JOURNAL OF CANCER (2016)
Verteporfin can Reverse the Paclitaxel Resistance Induced by YAP Over-Expression in HCT-8/T Cells without Photoactivation through Inhibiting YAP Expression
Wang Pan et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2016)
Non-Photoinduced Biological Properties of Verteporfin
Floriane Gibault et al.
CURRENT MEDICINAL CHEMISTRY (2016)
Photodynamic therapy: current role in the treatment of chorioretinal conditions
D. K. Newman
EYE (2016)
Mechanisms of Hippo pathway regulation
Zhipeng Meng et al.
GENES & DEVELOPMENT (2016)
Pluronic (R) P123/F127 mixed micelles delivering sorafenib and its combination with verteporfin in cancer cells
Diogo Silva Pellosi et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2016)
XPO1-dependent nuclear export is a druggable vulnerability in KRAS-mutant lung cancer
Jimi Kim et al.
NATURE (2016)
The Hippo Pathway and YAP/TAZ-TEAD Protein-Protein Interaction as Targets for Regenerative Medicine and Cancer Treatment
Matteo Santucci et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Microenvironment rigidity modulates responses to the HER2 receptor tyrosine kinase inhibitor lapatinib via YAP and TAZ transcription factors
Chun-Han Lin et al.
MOLECULAR BIOLOGY OF THE CELL (2015)
Verteporfin Photodynamic Therapy for the Treatment of Retinal Vasoproliferative Tumors
Rumana N. Hussain et al.
OPHTHALMOLOGY (2015)
NF2 Loss Promotes Oncogenic RAS-Induced Thyroid Cancers via YAP-Dependent Transactivation of RAS Proteins and Sensitizes Them to MEK Inhibition
Maria E. R. Garcia-Rendueles et al.
CANCER DISCOVERY (2015)
Phase I/II study of verteporfin photodynamic therapy in locally advanced pancreatic cancer
M. T. Huggett et al.
BRITISH JOURNAL OF CANCER (2014)
Treatment of posterior uveal melanoma with multi-dose photodynamic therapy
Paul Rundle
BRITISH JOURNAL OF OPHTHALMOLOGY (2014)
Mutant Gq/11 Promote Uveal Melanoma Tumorigenesis by Activating YAP
Fa-Xing Yu et al.
CANCER CELL (2014)
Induction of Covalently Crosslinked p62 Oligomers with Reduced Binding to Polyubiquitinated Proteins by the Autophagy Inhibitor Verteporfin
Elizabeth Donohue et al.
PLOS ONE (2014)
The Autophagy Inhibitor Verteporfin Moderately Enhances the Antitumor Activity of Gemcitabine in a Pancreatic Ductal Adenocarcinoma Model
Elizabeth Donohue et al.
JOURNAL OF CANCER (2013)
Evaluation of verteporfin pharmakokinetics - redefining the need of photosensitizers in ophthalmology
Focke Ziemssen et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2012)
Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP
Yi Liu-Chittenden et al.
GENES & DEVELOPMENT (2012)
CLINICAL AND HISTOPATHOLOGIC FINDINGS AFTER PHOTODYNAMIC THERAPY OF CHOROIDAL MELANOMA
Irene Canal-Fontcuberta et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2012)
Akt-Mediated Regulation of Autophagy and Tumorigenesis Through Beclin 1 Phosphorylation
Richard C. Wang et al.
SCIENCE (2012)
Inhibition of Autophagosome Formation by the Benzoporphyrin Derivative Verteporfin
Elizabeth Donohue et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version
Bin Zhao et al.
GENES & DEVELOPMENT (2010)
Permanent Occlusion of Feeding Arteries and Draining Veins in Solid Mouse Tumors by Vascular Targeted Photodynamic Therapy (VTP) with Tookad
Noa Madar-Balakirski et al.
PLOS ONE (2010)
Disparity between prostate tumor interior versus peripheral vasculature in response to verteporfin-mediated vascular-targeting therapy
Bin Chen et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Intravital high-resolution optical imaging of individual vessel response to photodynamic treatment
Mamta Khurana et al.
JOURNAL OF BIOMEDICAL OPTICS (2008)
Intravital microscopic analysis of vascular perfusion and macromolecule extravasation after photodynamic vascular targeting therapy
Chong He et al.
PHARMACEUTICAL RESEARCH (2008)
Antitumor effects and blood flow dynamics after photodynamic therapy using benzoporphyrin derivative monoacid ring A in KLN205 and LM8 mouse tumor models
Tomohiro Osaki et al.
CANCER LETTERS (2007)
Antiangiogenic photodynamic therapy (PDT) using Visudyne causes effective suppression of tumor growth
K Ichikawa et al.
CANCER LETTERS (2004)
Verteporfin ocular photodynamic therapy
SJ Bakri et al.
EXPERT OPINION ON PHARMACOTHERAPY (2004)
Photodynamic therapy targeted to tumor-induced angiogenic vessels
K Kurohane et al.
CANCER LETTERS (2001)
TEAD/TEF transcription factors utilize the activation domain of YAP65, a Src/Yes-associated protein localized in the cytoplasm
A Vassilev et al.
GENES & DEVELOPMENT (2001)
分享论文
